STSS
Sharps Technology Inc
-19.31%
$1.45 - $1.17
Feb 7th 2023 - Mar 21st 2023
Feb, 3, 2023
These polymer syringes have many of the same chara... See more
Jan, 31, 2023
The launch of these products could not come at a b... See more
Mar, 13, 2023
fed is getting this right protecting deposits of customers.
No reviews available.
Feb, 3, 2023
These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long term drug stability and increase shelf life for customers in the pharmaceutical segment.
Jan, 31, 2023
The launch of these products could not come at a better time to support a market that is in demand for products produced in the US that provide speciali zed solutions for customers that need options for their drug-filling operations.
Jan, 20, 2023
The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.
Jan, 19, 2023
The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.
Jan, 18, 2023
These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long-term drug stability and increase shelf life for customers in the pharmaceutical segment.
Jan, 18, 2023
The launch of these products could not come at a better time to support a market that is in demand for products produced in the USA that provide specialized solutions for customers that need options for their drug-filling operations.
Jan, 11, 2023
as they put out more great news on Europe customers and white label deals this will rocket one day Tuttes fucking with it building positions
Jan, 11, 2023
These polymer syringes have many of the same characteristics as current pharmaceutical glass designs to support long term drug stability and increase shelf life for customers in the pharmaceutical segment.
Jan, 11, 2023
$STSS love the fact 3 deals in play in regards to Hungary vial draw syringes.. European direct customers and another private label for USA market.. That is huge
Nov, 30, 2022
These new customer projects will fuel the growth of both companies, and the opportunity to create new technologies to support the healthcare industry will be transformative for Nephron and Sharps as they navigate a bright future working together.